3 Healthcare Stock Stories for Midweek Investment Wellness
Cerus Corporation (NASDAQ:CERS): Closing price $5.22 On Wednesday, Cerus announced that the FDA has accepted its proposed modular Premarket Approval application shell for review of the INTERCEPT Blood...
View ArticleWill Arena Pharmaceuticals See Rising Prices?
With shares of Arena Pharmaceuticals (NASDAQ:ARNA) trading around $8, is ARNA an OUTPERFORM, WAIT AND SEE or STAY AWAY? Let’s analyze the stock with the relevant sections of our CHEAT SHEET investing...
View Article4 Healthcare Stock Stories Buzzing Along On Monday
Vivus (NASDAQ:VVUS): Closing price $12.41 On Monday, Vivus reported that the initial availability of Qsymia (phentermine and topiramate extended-release) capsules CIV in thousands of certified retail...
View ArticleBiomarin Pharmaceutical: Here’s What Investors Need to Know Before Earnings
Biomarin Pharmaceutical (NASDAQ:BMRN) will report earnings after markets close on Thursday, July 25th. BioMarin Pharmaceutical Inc. develops and commercializes therapeutic enzyme products. The Company...
View ArticleJim Cramer: Buy ARM Holdings, Sell Baidu, and 2 More Stock Picks
Jim Cramer made the following calls on September 17th, 2013. What do you think about his picks? ARM Holdings plc (NASDAQ:ARMH): Jim Cramer ranked this stock a Buy. Cramer previously ranked this stock a...
View ArticleAnalysts: Aeropostale May Have Margin Concerns and 3 Other Research Notes to...
Aeropostale (NYSE:ARO): Maxim lowered its price target for Aeropostale shares to $9 from $14, citing ongoing margin concerns, and the firm keeps a Hold rating on the stock. Regarding Sycamore’s 7.96...
View Article4 Mergers and Acquisitions Stock Stories for Thursday Due Diligence
International Business Machines Corp. (NYSE: IBM): Current price $193.62 IBM announced Thursday that it purchased Daeja Image Systems Ltd., which provides software that facilitates businesses and...
View Article4 Healthcare Stock Stories Making a Big Buzz Today
Merck & Co. (NYSE: MRK): Closing price $48.75 On Tuesday, Goldman Sachs maintained its Neutral on Merck and raised its price target from $52 to $54. Analyst Jami Rubin professed to be encouraged by...
View ArticleJim Cramer: Buy AMD, Anadarko, and These 3 Stocks
Jim Cramer made the following calls on October 2nd, 2013. What do you think about his picks? Advanced Micro Devices, Inc. (NYSE:AMD): Jim Cramer ranked this stock a Buy. Cramer previously ranked this...
View ArticleJim Cramer: Buy Apple, BioMarin, and These 3 Stocks
Jim Cramer made the following calls on October 21. What do you think about his picks? Apple Inc. (NASDAQ:AAPL): Jim Cramer ranked this stock a Buy. Cramer previously ranked this stock a Buy on...
View Article
More Pages to Explore .....